Citation tools

Hidestrand, Mats et al "CYP2B6 and CYP2C19 as the Major Enzymes Responsible for the Metabolism of Selegiline, a Drug Used in the Treatment of Parkinson's Disease, as Revealed from Experiments with Recombinant Enzymes." Drug Metabolism and Disposition 29.11 (2001): 1480-1484. Web. 28 Mar. 2023.